[Controversies regarding the use of statins in the acute coronary syndrome].
Camps
D
D
D054058:Acute Coronary Syndrome / Q000188:drug therapy* / Q000378:metabolism; D000075202:Contraindications; D004579:Electron Transport / Q000187:drug effects; D019317:Evidence-Based Medicine; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D008798:Mevalonic Acid / Q000378:metabolism; D008929:Mitochondria, Heart / Q000187:drug effects / Q000378:metabolism; D012345:RNA, Transfer, Amino Acid-Specific / Q000378:metabolism; D014451:Ubiquinone / Q000378:metabolism
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D012345:RNA, Transfer, Amino Acid-Specific; C036928:tRNA, selenocysteine-; D014451:Ubiquinone; D008798:Mevalonic Acid